{"id":59486,"date":"2024-02-28T06:00:08","date_gmt":"2024-02-28T06:00:08","guid":{"rendered":"https:\/\/medsname.com\/angispan-tr\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"angispan-tr","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nb\/product\/angispan-tr\/","title":{"rendered":"Angispan-TR"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Angispan-TR?<\/h3>\n<p style=\"margin:0;\"><strong>Angispan-TR<\/strong> er en <strong>nitroglycerin (glyceryl trinitrate) 6.5&nbsp;mg time-release capsule<\/strong>, used for daily <em>profylakse<\/em> of chronic stable angina. The usual dose is <strong>one capsule twice daily<\/strong>, taken 7&nbsp;hours apart (e.g. 7&nbsp;a.m. and 2&nbsp;p.m.) to preserve an <strong>8&ndash;12 hour overnight nitrate-free interval<\/strong>. Angispan-TR is <strong>ikke<\/strong> a rescue medication for acute attacks &mdash; keep sublingual nitroglycerin for that.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Hva du f\u00e5r med MedsBase:<\/strong> WHO-GMP-sertifisert produsent \u00b7 Diskret emballasje \u00b7 Verdensomspennende levering \u00b7 1 400+ verifiserte <a href=\"https:\/\/medsbase.com\/nb\/reviews\/\">kundeanmeldelser<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Hver ordre er dekket av v\u00e5r <a href=\"https:\/\/medsbase.com\/nb\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n<h3>Hvorfor bestille fra MedsBase<\/h3>\n<p>V\u00e5re generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, n\u00f8ytral emballasje \u2014 ingen legemiddelnavn p\u00e5 utsiden av pakken. Kortbetalinger h\u00e5ndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor \u2014 aldri \u201cMedsBase\u201d eller noe legemiddelnavn). Krypto og SEPA bankoverf\u00f8rsel godtas ogs\u00e5. Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy.<\/p>\n<p><strong>Angispan-TR 6.5&nbsp;mg<\/strong> is a time-release (TR) oral nitroglycerin capsule. &ldquo;TR&rdquo; stands for &ldquo;Time Release&rdquo; &mdash; the capsule is engineered to release its 6.5&nbsp;mg of glyceryl trinitrate gradually over 6&ndash;8 hours, giving steady anti-anginal cover during the active part of the day without the peak-and-trough swings of short-acting nitrates.<\/p>\n<p>Angispan-TR is prescribed across India and Southeast Asia as a mainstream long-term anti-anginal agent, often as the first choice when sublingual rescue doses alone are not enough to keep a patient symptom-free. Typical patients are those with stable coronary artery disease whose chest pain limits their daily activity, who cannot tolerate beta-blocker-only therapy, or who need combination therapy after diagnosis.<\/p>\n<h2 class=\"wp-block-heading\">What Is Angispan-TR Used For?<\/h2>\n<p>Angispan-TR is indicated for:<\/p>\n<ul>\n<li><strong>Chronic stable angina pectoris<\/strong> &mdash; reducing chest pain frequency and severity<\/li>\n<li><strong>Effort-induced ischaemia<\/strong> &mdash; pre-medication before reliable triggers (walking outdoors in the cold, stair climbing)<\/li>\n<li><strong>Variant (Prinzmetal) angina<\/strong> &mdash; coronary artery spasm<\/li>\n<li><strong>Heart failure with ischaemic component<\/strong> &mdash; preload reduction<\/li>\n<\/ul>\n<p>Det er <em>ikke<\/em> appropriate for an acute episode. Onset is 30&ndash;60 minutes, far too slow to abort an ongoing attack. Every patient on Angispan-TR should also carry sublingual nitroglycerin or a sublingual isosorbide dinitrate 5 mg (Sorbitrate) tablet for rescue.<\/p>\n<h2 class=\"wp-block-heading\">Hvordan Virker Nitrater?<\/h2>\n<p>Alle nitratmedikamenter har samme virkemekanisme. Etter opptak omdannes de enzymatisk til <strong>nitrogenmonoksid (NO)<\/strong> inne i glatt muskulatur i blod\u00e5rene. NO aktiverer guanylatcyklase, som \u00f8ker intracellul\u00e6rt cGMP og slapper av glatt muskulatur i blod\u00e5rene. De kliniske effektene er:<\/p>\n<ul>\n<li><strong>Ven\u00f8s dilatasjon<\/strong> (dominerende ved lave doser) \u2014 reduserer ven\u00f8s retur til hjertet, og senker <em>preload<\/em>. Dette er hvordan nitrater reduserer hjertets oksygenbehov.<\/li>\n<li><strong>Arteriell dilatasjon<\/strong> (h\u00f8yere doser) \u2014 reduserer systemisk vaskul\u00e6r motstand og <em>afterload<\/em>, og reduserer dermed hjertets arbeidsbelastning ytterligere.<\/li>\n<li><strong>Koronar arterie dilatasjon<\/strong> \u2014 forbedrer blodstr\u00f8mmen til iskemiske omr\u00e5der av hjertemuskelen, spesielt ved koronar spasme.<\/li>\n<\/ul>\n<p>Nettoeffekten er mindre brystsmerter, f\u00e6rre anginaepisoder og bedret treningskapasitet hos pasienter med stabil koronar hjertesykdom.<\/p>\n<h2 class=\"wp-block-heading\">Nitrattoleranse \u2014 den kritiske doseringsregelen<\/h2>\n<p>Nitrattoleranse er det viktigste konseptet for enhver pasient som bruker nitrater. Hvis et nitrat gis d\u00f8gnet rundt \u2014 med stabile blodniv\u00e5er i 24 timer i d\u00f8gnet \u2014 vil den anti-angin\u00f8se effekten avta innen 48 til 72 timer. Dette er et veldokumentert, reproduserbart farmakologisk fenomen, ikke en innbilt effekt.<\/p>\n<p>L\u00f8sningen er enkel og ikke til forhandling: hver 24-timers syklus m\u00e5 inkludere en <strong>nitratfri periode p\u00e5 minst 8\u201312 timer<\/strong>, vanligvis over natten. De vanligste strategiene er:<\/p>\n<ul>\n<li>Asymmetrisk dosering to ganger daglig (f.eks. kl. 07.00 og 15.00, ingen inntak etter det til neste morgen)<\/li>\n<li>Engangsdoser med langtidsvirkende form\u00e5l som gir lav bunnverdi<\/li>\n<li>Fjerne et transdermalt plaster etter 12\u201314 timer p\u00e5 huden<\/li>\n<\/ul>\n<p>Gj\u00f8r <em>ikke<\/em> ta ekstra doser \u201cved leggetid\u201d eller om natten med mindre legen eksplisitt har foreskrevet d\u00f8gnkontinuerlig behandling av en spesifikk grunn.<\/p>\n<h2 class=\"wp-block-heading\">Angispan-TR Dosing<\/h2>\n<p>Ved kronisk stabil angina hos voksne:<\/p>\n<ul>\n<li><strong>Vanlig dose:<\/strong> One capsule (6.5 mg) twice daily &mdash; morning and early afternoon<\/li>\n<li><strong>Tidspunkt:<\/strong> Doses should be 6&ndash;7 hours apart to give coverage through the active day, with a clear 14&ndash;17 hour nitrate-free interval overnight. Typical pattern: 7&nbsp;a.m. and 2&nbsp;p.m., then nothing until the next morning<\/li>\n<li><strong>Upward titration:<\/strong> If symptoms persist, some cardiologists go to 6.5 mg three times daily (avoid dosing after 4&nbsp;p.m.), or to a 13 mg twice-daily regimen. Most patients do better with a switch to isosorbide mononitrate (Monit) rather than higher NTG SR doses<\/li>\n<li><strong>Capsule handling:<\/strong> Swallow whole with water. Do not open, chew, or crush &mdash; this destroys the time-release matrix<\/li>\n<\/ul>\n<p>If you miss a dose, take it when you remember unless your next dose is due within 3 hours &mdash; then skip it. Never double up.<\/p>\n<p>In older patients (over 70), hepatic impairment, or alongside antihypertensives, start at the lowest dose and titrate cautiously; Angispan-TR can drop blood pressure noticeably in these groups.<\/p>\n<h2 class=\"wp-block-heading\">Who Should Not Take Angispan-TR?<\/h2>\n<p>Det er \u00e9n absolutt kontraindikasjon som alle pasienter m\u00e5 forst\u00e5 f\u00f8r f\u00f8rste dose:<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:16px 0;border-radius:4px;\">\n<p style=\"margin:0;\"><strong>Kombiner aldri nitrat med en PDE5-hemmer.<\/strong> Sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra) og avanafil (Stendra) forsterker vasodilatatoreffekten av nitrater og kan for\u00e5rsake livstruende hypotensjon, kollaps, slag eller hjerteinfarkt. Vent minst <strong>24 timer etter sildenafil\/vardenafil<\/strong> og <strong>48 timer etter tadalafil<\/strong> f\u00f8r inntak av enhver nitratdose. Dette gjelder alle former \u2014 orale, sublinguale, transdermale og spray.<\/p>\n<\/div>\n<p>Andre viktige kontraindikasjoner:<\/p>\n<ul>\n<li>Alvorlig hypotensjon eller hypovolemi (systolisk BT &lt; 90 mmHg)<\/li>\n<li>Alvorlig anemi (nitrater kan forverre vevsoksygentilf\u00f8rsel)<\/li>\n<li>Hypertrofisk obstruktiv kardiomyopati (HOCM) \u2014 nitrater kan forverre utstr\u00f8mshindring<\/li>\n<li>Alvorlig aortastenose \u2014 risiko for syncope<\/li>\n<li>Forh\u00f8yet intrakranielt trykk eller nylig hodeskade<\/li>\n<li>H\u00f8yreventrikkelinfarkt \u2014 preload er essensielt, nitrater reduserer det<\/li>\n<li>Konstriktiv perikarditt eller hjerdetamponade<\/li>\n<li>Kjent overf\u00f8lsomhet for organiske nitrater<\/li>\n<li>Samtidig bruk av l\u00f8selige guanylatcyklase-stimulatorer (riociguat)<\/li>\n<\/ul>\n<p>Bruk med forsiktighet under graviditet (kategori C) og diskuter med en spesialist. Ved amming er tilfeldig bruk generelt akseptert, men rutinemessig terapi b\u00f8r vurderes med en kardiolog.<\/p>\n<h2 class=\"wp-block-heading\">Common Side Effects of Angispan-TR<\/h2>\n<p>De fleste bivirkningene av nitrater skyldes direkte utvidelse av deres vasodilatoriske virkning og pleier \u00e5 avta i l\u00f8pet av de f\u00f8rste 1\u20132 ukene med behandling.<\/p>\n<p><strong>Sv\u00e6rt vanlig (&gt;10 % av pasientene):<\/strong><\/p>\n<ul>\n<li><strong>Hodepine<\/strong> \u2014 bankende, frontal hodepine, ofte verst i de f\u00f8rste dagene. Paracetamol er trygt. Hodepinen forsvinner vanligvis innen 7\u201314 dager etter hvert som kroppen tilpasser seg; det er <em>ikke<\/em> et tegn p\u00e5 overdose.<\/li>\n<li>Svimmelhet eller f\u00f8lelse av \u00e5 v\u00e6re lett i hodet, spesielt ved oppreist stilling<\/li>\n<li>Ansiktsr\u00f8dme<\/li>\n<\/ul>\n<p><strong>Vanlige (1\u201310%):<\/strong><\/p>\n<ul>\n<li>Postural hypotensjon<\/li>\n<li>Refleks takykardi (h\u00f8y puls)<\/li>\n<li>Kvalme, av og til oppkast<\/li>\n<li>Hudutslett (hyppigere ved bruk av transdermal plaster)<\/li>\n<\/ul>\n<p><strong>Sjeldne, men viktige:<\/strong><\/p>\n<ul>\n<li>Synkope (besvimelse) \u2014 vanligvis ved f\u00f8rste dose, ved \u00e5 reise seg, eller etter alkohol<\/li>\n<li>Paradoksalt forverring av angina \u2014 sjeldent; s\u00f8k \u00f8yeblikkelig vurdering<\/li>\n<li>Methemoglobinemi \u2014 sv\u00e6rt sjeldent, ved vedvarende h\u00f8y dose-behandling<\/li>\n<\/ul>\n<p>Stopp medisinen og kontakt legen din umiddelbart hvis du utvikler alvorlig eller vedvarende hodepine som ikke avtar, besvimelsesanfall, et bl\u00e6redannende utslett, eller bl\u00e5fargede lepper og hud.<\/p>\n<h2 class=\"wp-block-heading\">Angispan-TR vs Angiplat &mdash; What is the Difference?<\/h2>\n<p>Both Angispan-TR and Angiplat are sustained-release oral nitroglycerin capsules. The difference is dose per capsule:<\/p>\n<ul>\n<li><strong>Angiplat 2.5&nbsp;mg<\/strong> &mdash; lower starting dose, more flexible titration, useful in elderly and low-BP patients<\/li>\n<li><strong>Angispan-TR 6.5&nbsp;mg<\/strong> &mdash; higher per-dose delivery, simpler twice-daily schedule, preferred when angina is not fully controlled on lower doses<\/li>\n<\/ul>\n<p>Both products follow the same tolerance rules and the same contraindications &mdash; they are clinically interchangeable at equivalent daily doses. Do not combine them on the same day.<\/p>\n<h2 class=\"wp-block-heading\">Angispan-TR vs Isosorbide Mononitrate (Monit)<\/h2>\n<p>Some cardiologists prefer <strong>isosorbidmononitrat (ISMN)<\/strong> over oral sustained-release nitroglycerin because ISMN has 100% oral bioavailability (no first-pass metabolism) and more predictable pharmacokinetics. Angispan-TR still has a role when:<\/p>\n<ul>\n<li>The patient has a stable response and tolerates it well<\/li>\n<li>Twice-daily dosing is preferred to ISMN&#8217;s &ldquo;7&nbsp;a.m.&nbsp;+ 3&nbsp;p.m.&rdquo; asymmetric schedule<\/li>\n<li>Local availability or cost favours nitroglycerin SR<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Bestilling og levering<\/h2>\n<p>MedsBase tilbyr verdensomspennende levering p\u00e5 alle bestillinger. Bestillinger sendes i diskrete emballasjer og ankommer i merkevareprodusentens pakninger. Peptider og de fleste kardiovaskul\u00e6re generika er p\u00e5 lager i flere styrker; hvis din foretrukne pakningsst\u00f8rrelse er utsolgt, kontakt kundeservice for en estimert leveringstid.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:20px 0;border-radius:4px;\">\n<p style=\"margin:0;\"><strong>Medisinsk ansvarsfraskrivelse.<\/strong> Informasjonen p\u00e5 denne siden er kun til generell opplysning. Den er ikke erstatning for r\u00e5d fra din egen lege eller kardiolog. Nitrater er potente kardiovaskul\u00e6re legemidler med kjente alvorlige interaksjoner. Snakk med en kvalifisert helsepersonell f\u00f8r du starter, stopper eller endrer behandling, og s\u00f8k umiddelbar medisinsk hjelp hvis brystsmertene er nye, mer alvorlige eller varer lenger enn 10\u201315 minutter.<\/p>\n<\/div>\n<h2 id=\"faqs\">Vanlige sp\u00f8rsm\u00e5l<\/h2>\n<h3 class=\"wp-block-heading\">Can I use Angispan-TR to stop an angina attack?<\/h3>\n<p>No. Angispan-TR has an onset of 30&ndash;60 minutes &mdash; too slow for an acute episode. Use sublingual nitroglycerin or sublingual isosorbide dinitrate (Sorbitrate) 5 mg for rescue.<\/p>\n<h3 class=\"wp-block-heading\">Can I take Angispan-TR with sildenafil, tadalafil or vardenafil?<\/h3>\n<p>No &mdash; this combination is absolutely contraindicated. PDE5 inhibitors potentiate the blood-pressure drop from nitrates and can be fatal. Allow 24 hours after sildenafil\/vardenafil and 48 hours after tadalafil before any nitrate dose.<\/p>\n<h3 class=\"wp-block-heading\">Why do I get headaches on Angispan-TR?<\/h3>\n<p>Nitrate headache is caused by cerebral vasodilation and is extremely common in the first week. Most patients find it fades on its own after 7&ndash;14 days. Paracetamol is safe. Persistent severe headache is a reason to reduce dose or switch to ISMN.<\/p>\n<h3 class=\"wp-block-heading\">Why do I need an 8-hour nitrate-free interval?<\/h3>\n<p>Without a nitrate-free interval, your body develops tolerance within 48&ndash;72 hours and the medication stops controlling angina. The overnight break restores drug efficacy the following day.<\/p>\n<h3 class=\"wp-block-heading\">What happens if I open or chew the capsule?<\/h3>\n<p>The entire 6.5 mg is released at once. This causes a large, rapid drop in blood pressure, severe headache, and loss of the prolonged effect. Always swallow the capsule whole.<\/p>\n<h3 class=\"wp-block-heading\">Can I take Angispan-TR with my beta-blocker and calcium channel blocker?<\/h3>\n<p>Yes, this is standard triple anti-anginal therapy. All three classes reduce ischaemia through different mechanisms. Monitor for dizziness and low blood pressure, especially in the first two weeks.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol while taking Angispan-TR?<\/h3>\n<p>Light alcohol with food is usually tolerated, but alcohol is a vasodilator and can worsen hypotension and dizziness. Avoid heavy drinking.<\/p>\n<h3 class=\"wp-block-heading\">Is Angispan-TR safe long-term?<\/h3>\n<p>Yes, provided the nitrate-free interval is respected. Many patients take sustained-release nitroglycerin for years. Annual review with your cardiologist is recommended.<\/p>\n<h3 class=\"wp-block-heading\">Can I stop Angispan-TR suddenly if I feel better?<\/h3>\n<p>No &mdash; abrupt withdrawal of a long-acting nitrate can cause rebound coronary vasospasm and worsening angina. Any taper must be medically supervised.<\/p>\n<h3 class=\"wp-block-heading\">What if I miss a dose of Angispan-TR?<\/h3>\n<p>Take it as soon as you remember, unless your next dose is due within 3 hours &mdash; then skip the missed one. Never double up.<\/p>\n<h3 class=\"wp-block-heading\">Can I drive while on Angispan-TR?<\/h3>\n<p>Once stable and headache-free, yes. Avoid driving during the first week, after any dose change, or if you feel dizzy.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterte alternativer<\/h3>\n<p>Andre produkter innen <strong>Kroniske tilstander<\/strong> som kunder ogs\u00e5 ser p\u00e5:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/nb\/losar\/\">Losar<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/ciclohale\/\">Ciclohale<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/barinat\/\">Barinat<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/tenof-em\/\">Tenof EM<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/cytotam\/\">Cytotam<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Relieves chest pain<br \/>\n\u2705 Dilates blood vessels<br \/>\n\u2705 Treats angina attacks<br \/>\n\u2705 Forbedrer blodsirkulasjonen<br \/>\n\u2705 Prevents heart pain<\/p>\n<p>Angispan-TR contains Nitroglycerin.<\/p>","protected":false},"featured_media":59487,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260],"product_tag":[4704,4522],"class_list":{"0":"post-59486","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_tag-angispan-tr","10":"product_tag-nitroglycerin","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product\/59486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/comments?post=59486"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media\/59487"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media?parent=59486"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_brand?post=59486"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat?post=59486"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_tag?post=59486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}